125 filings
S-8
IVVD
Invivyd Inc
9 May 24
Registration of securities for employees
4:32pm
10-Q
2024 Q1
IVVD
Invivyd Inc
Quarterly report
9 May 24
4:20pm
8-K
IVVD
Invivyd Inc
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
8-K
IVVD
Invivyd Inc
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
EFFECT
IVVD
Invivyd Inc
22 Apr 24
Notice of effectiveness
12:15am
ARS
q8qaaiv0mv17 d8
18 Apr 24
Annual report to shareholders
4:15pm
8-K
kroczd eqxqq3ts5e
12 Apr 24
Invivyd Announces CEO Transition
7:36am
8-K
2si05yg86 dg8cxd589x
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
3u0byyc nt
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
d82xc7z
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDAâ„¢ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
swvajcig
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
1hyuuy7c
8 Jan 24
Other Events
7:12am
8-K
uofaviz3chm xe1
3 Jan 24
Other Events
7:06am
8-K
ijn6bpo2
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
85nellj6hhkfhuk8b8
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
jp1fnsg0
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
or32 0pb9hwh
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm